One dose of synthetic psilocybin in combination with psychotherapy significantly reduces treatment-resistant depression associated with bipolar II disorder (BDII), a small, nonrandomized clinical ...

A study, published this month in the journal JAMA Psychiatry, sought to determine whether “a single psychedelic dose of psilocybin with psychotherapy demonstrate[s] evidence for efficacy and/or safety ...

It is well-proven that cannabis use is associated with an increased risk of schizophrenia and heavy use of high-THC marijuana is associated with four times the normal rate of schizophrenia (see my ...

Baylor College of Medicine received nearly $10 million in funding from the NIH BRAIN Initiative to study effective treatments for the depressive phase of bipolar disorder. In the span of five years, ...

Having bipolar disorder -- a serious mental illness that can cause both manic and depressed moods -- can make life more challenging. It also comes with a higher risk of dying early. Now, a study puts ...

Imagine wading through severe depression for years, taking medication after medication, with no relief. Now, envision discovering that what you were facing was not major depression but bipolar ...